LONZA N |
Date/Time | / |
Chg. / Chg.(%) | - / |
Bid | - |
Ask | - |
Open | - |
Previous Close | - |
High | - |
Low | - |
Volume [CHF] | - |
Volume [Units] | |
Price fixings | |
ISIN | CH0013841017 |
Security | LONN |
Exchange | SIX Swiss Exchange |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
SIX Swiss Ex.. | 583.20 | ![]() |
103,291 |
London Inter.. | 582.40 | ![]() |
2,237 |
Lang & Schwa.. | 540.800 | ![]() |
|
Nasdaq Other.. | 663.0400 | ![]() |
103 |
Mexico | 13,159.94 | ![]() |
270 |
Cboe Europe .. | 328.30 | 47,868 | |
Turquoise | 328.30 | ![]() |
18,782 |
Cboe Europe .. | 328.00 | 12,923 | |
TradeGate | 294.000 | 298 | |
Frankfurt | 293.9000 | 63 | |
Düsseldorf | 291.20 | 0 | |
München | 291.30 | 0 | |
Berlin | 296.90 | 0 | |
Hamburg | 291.30 | 0 | |
gettex | 296.100 | ||
Singapore | 79.97 | 500 | |
EUREX | Options |
News
- WOCHENVORSCHAU: Termine bis 29. Januar 2021
06:05 - APA/dpa-AFX - Aktien Zürich Schluss: SMI rettet knappes Plus über den Tag
01/14/2021 / 18:06 - dpa-AFX - Capricor Collaborates with Lonza for the Development of CAP-1002, its Cell Therapy Candidate for the Treatment of Duchenne Muscular Dystrophy and Other Indications
01/12/2021 / 15:05 - GlobeNewswire - Moderna-Impfstoff auch in der Schweiz zugelassen
01/12/2021 / 13:59 - dpa-AFX - Achilles Therapeutics Appoints Arjan Roozen as VP, Site Head and General Manager
01/08/2021 / 13:00 - GlobeNewswire